Morphine sulfate and Status epilepticus - a phase IV clinical study of FDA data

Summary:

Status epilepticus is reported as a side effect among people who take Morphine sulfate (morphine sulfate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Paracetamol, and have Epilepsy.

The phase IV clinical study analyzes which people have Status epilepticus when taking Morphine sulfate. It is created by eHealthMe based on reports of 86,091 people who have side effects when taking Morphine sulfate from the FDA, and is updated regularly.

What is Morphine sulfate?

Morphine sulfate has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 87,262 Morphine sulfate users. Check the latest studies of Morphine sulfate.

What is Status epilepticus?

Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure) is found to be associated with 662 drugs and 949 conditions by eHealthMe. Check the latest studies of Status epilepticus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

86,091 people reported to have side effects when taking Morphine sulfate.
Among them, 54 people (0.06%) have Status epilepticus.

Could Morphine sulfate cause Status epilepticus?

Among these 54 people:

How long have people been on Morphine sulfate when they have Status epilepticus? *

What is the gender of people who have Status epilepticus when taking Morphine sulfate? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Status epilepticus when taking Morphine sulfate? *

What are other drugs people take besides Morphine sulfate? *

Ondansetron: 7 people, 12.96%
Paracetamol: 7 people, 12.96%
Clobazam: 6 people, 11.11%
Zopiclone: 5 people, 9.26%
Phytomenadione: 5 people, 9.26%
Piperacillin And Tazobactam: 5 people, 9.26%
N-Acetylcysteine: 5 people, 9.26%
Gastrografin: 5 people, 9.26%
Morphine: 4 people, 7.41%
Lorazepam: 4 people, 7.41%

What are other side effects people have besides Status epilepticus? *

Encephalopathy (functioning of the brain is affected by some agent or condition): 11 people, 20.37%
Hypotension (abnormally low blood pressure): 8 people, 14.81%
High Blood Pressure: 8 people, 14.81%
Respiratory Depression (respiration has a rate below 12 breaths): 6 people, 11.11%
Abdominal Pain: 5 people, 9.26%
Depressed Level Of Consciousness: 4 people, 7.41%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 4 people, 7.41%
Leukopenia (less number of white blood cells in blood): 4 people, 7.41%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 4 people, 7.41%
Hypokalemia (low potassium): 4 people, 7.41%

What are the existing conditions these people have? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 11.11%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 5 people, 9.26%
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch): 4 people, 7.41%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 7.41%
Joint Pain: 4 people, 7.41%
Anaesthesia: 3 people, 5.56%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 2 people, 3.70%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 3.70%
Complications Of Transplanted Kidney: 2 people, 3.70%
Uveitis (inflammation of the uvea): 1 person, 1.85%

* Approximation only. Some reports may have incomplete information.

Do you take Morphine sulfate and have Status epilepticus?

- Check whether Status epilepticus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Morphine sulfate:

Morphine sulfate (87,262 reports)

Browse all side effects of Morphine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Status epilepticus:

Status epilepticus (662 drugs)

Browse all the conditions that are associated with Status epilepticus:

Status epilepticus (949 conditions)

Related publications that referenced our studies

Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate (the active ingredients of Morphine sulfate) and Morphine sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.